Headshot of André Fenton.

André Fenton

Professor
New York University

André Fenton is professor of neural science and director of the Center for Neural Science at New York University. He investigates the molecular, neural, behavioral and computational aspects of memory. He studies how brains store experiences as memories, how they learn to learn, and how knowing activates relevant information without activating what is irrelevant. These investigations are founded in how the brain computes knowledge of space, particularly the locations and directions that are the framework for experience. His investigations integrate across levels of biological organization; his research uses genetic, molecular, electrophysiological, imaging, behavioral, engineering and theoretical methods. This computational psychiatry research is helping to elucidate mental dysfunction in diverse conditions, including schizophrenia, autism, and depression.

Fenton founded BioSignal Group, Corp., which commercialized an FDA-approved portable, wireless and easy-to-use platform for recording EEGs in novel medical applications. He implemented a CPAP-oxygen-helmet treatment for COVID-19 in Nigeria and other low- and middle-income countries, and he develops information technology for the patient-centric coordination of behavioral health services that is desperately needed to equitably deliver care for mental health. Fenton hosted PBS’ “NOVA Wonders,” and he chairs the National Institute of Mental Health’s Board of Scientific Counselors.

Explore more from The Transmitter

Research image of neurons in the fly’s ventral nerve cord.

New connectomes fly beyond the brain

Researchers are mapping the neurons in Drosophila’s ventral nerve cord, where the central nervous system meets the rest of the body.

By Laura Dattaro
26 July 2024 | 7 min read
Illustration of researchers talking to laypeople amidst strands of DNA.

Building an autism research registry: Q&A with Tony Charman

A purpose-built database of participants who have shared genomic and behavioral data could give clinical trials a boost, Charman says.

By Cathleen O’Grady
25 July 2024 | 8 min read

Cerebellar circuit may convert expected pain relief into real thing

The newly identified circuit taps into the brain’s opioid system to provide a top-down form of pain relief.

By Angie Voyles Askham
24 July 2024 | 6 min read